HY-P99007-1mg
|
MedChemexpress LLC
|
Aprutumab [CAS 1634620-63-5]
|
|
Cancer-Kinase/protease
|
|
HY-P99007-5mg
|
MedChemexpress LLC
|
Aprutumab [CAS 1634620-63-5]
|
|
Cancer-Kinase/protease
|
|
HY-P99010-1mg
|
MedChemexpress LLC
|
Bemarituzumab [CAS 1952272-74-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99010-10mg
|
MedChemexpress LLC
|
Bemarituzumab [CAS 1952272-74-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99010-5mg
|
MedChemexpress LLC
|
Bemarituzumab [CAS 1952272-74-0]
|
|
Cancer-Kinase/protease
|
|
HY-P99030-1mg
|
MedChemexpress LLC
|
Margetuximab [CAS 1350624-75-7]
|
|
Cancer-Kinase/protease
|
|
HY-P99030-10mg
|
MedChemexpress LLC
|
Margetuximab [CAS 1350624-75-7]
|
|
Cancer-Kinase/protease
|
|
HY-P99030-5mg
|
MedChemexpress LLC
|
Margetuximab [CAS 1350624-75-7]
|
|
Cancer-Kinase/protease
|
|
HY-P99041-1mg
|
MedChemexpress LLC
|
PanituMu mab [CAS 339177-26-3]
|
|
Cancer-Kinase/protease
|
|
HY-P99041-5mg
|
MedChemexpress LLC
|
PanituMu mab [CAS 339177-26-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-1mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-25mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-5mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9905-50mg
|
MedChemexpress LLC
|
Cetuximab [CAS 205923-56-4]
|
|
Cancer-Kinase/protease
|
|
HY-P9906-1mg
|
MedChemexpress LLC
|
Bevacizumab [CAS 216974-75-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9906-10mg
|
MedChemexpress LLC
|
Bevacizumab [CAS 216974-75-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9906-5mg
|
MedChemexpress LLC
|
Bevacizumab [CAS 216974-75-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9907-1mg
|
MedChemexpress LLC
|
Trastuzumab [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9907-25mg
|
MedChemexpress LLC
|
Trastuzumab [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9907-5mg
|
MedChemexpress LLC
|
Trastuzumab [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9907-50mg
|
MedChemexpress LLC
|
Trastuzumab [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9907A-1mg
|
MedChemexpress LLC
|
Trastuzumab (anti-HER2) [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9907A-10mg
|
MedChemexpress LLC
|
Trastuzumab (anti-HER2) [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9907A-5mg
|
MedChemexpress LLC
|
Trastuzumab (anti-HER2) [CAS 180288-69-1]
|
|
Cancer-Kinase/protease
|
|
HY-P9912-1mg
|
MedChemexpress LLC
|
Pertuzumab [CAS 380610-27-5]
|
|
Cancer-Kinase/protease
|
|